Efficacy of allylestrenol combined with ritodrine on threatened premature labor and its influence on inflammatory factors in peripheral blood

Li,Qing; Li,Chunhua; Jin,Hongmei

doi:10.3892/etm.2019.8273

Efficacy of allylestrenol combined with ritodrine on threatened premature labor and its influence on inflammatory factors in peripheral blood

Authors:
- Qing Li
- Chunhua Li
- Hongmei Jin
View Affiliations

Affiliations: Department of Obstetrics, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, P.R. China
Published online on: December 3, 2019 https://doi.org/10.3892/etm.2019.8273
Pages: 907-912
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Efficacy of allylestrenol combined with ritodrine on threatened premature labor (TPTL) and its influence on inflammatory factors in peripheral blood were investigated. A total of 206 cases of TPTL patients from 2014 to 2016 were collected in Zhongshan Hospital Affiliated to Fudan University, and 106 cases were treated with allylestrenol combined with ritodrine as a research group and 100 cases were treated with allylestrenol combined with magnesium sulfate as a control group. General information of patients was collected, and changes in the expression levels of IL‑17, IL‑10 and IL‑6 were detected by enzyme‑linked immunosorbent assay. Prolonged pregnancy time, success rate of fetal protection and average delivery time of patients were recorded. The adverse pregnancy conditions were compared, including the Apgar score of newborns, birth weight and adverse conditions, and postpartum hemorrhage volume and postpartum hospital stays in the two groups were recorded. Prolonged pregnancy time, success rate of fetal protection and average delivery time in the research group were significantly higher than those in the control group (P<0.05). After treatment, the levels of IL‑17, IL‑10 and IL‑6 in serum of the two groups were significantly lower than those before treatment (P<0.05), and were significantly lower in the research group than in the control group (P<0.05). The average neonatal weight and Apgar score in the research group were significantly better than those in the control group (P<0.05). Postpartum hemorrhage, postpartum hospital stays and incidence rate of toxic side effects, neonatal death, malformation and asphyxia in the research group were significantly lower than those in the control group (P<0.05). Allylestrenol combined with ritodrine can significantly reduce the expression levels of IL‑17, IL‑10 and IL‑6 in TPTL, reduce adverse pregnancy conditions, prolong gestational weeks, and has higher safety and better application value.

View Figures

View References

1	Roos C, Schuit E, Scheepers HC, Bloemenkamp KW, Bolte AC, Duvekot HJ, van Eyck J, Kok JH, Kwee A, Merién AE, et al for APOSTEL-II Study Group, : Predictive factors for delivery within 7 days after successful 48-hour treatment of threatened preterm labor. AJP Rep. 5:e141–e149. 2015. View Article : Google Scholar : PubMed/NCBI
2	Heng YJ, Taylor L, Larsen BG, Chua HN, Pung SM, Lee MW, Tucholska M, Tate S, Kupchak P, Pennell CE, et al: Albumin decrease is associated with spontaneous preterm delivery within 48 h in women with threatened preterm labor. J Proteome Res. 14:457–466. 2015. View Article : Google Scholar : PubMed/NCBI
3	Melamed N, Hiersch L, Gabbay-Benziv R, Bardin R, Meizner I, Wiznitzer A and Yogev Y: Predictive value of cervical length in women with twin pregnancy presenting with threatened preterm labor. Ultrasound Obstet Gynecol. 46:73–81. 2015. View Article : Google Scholar : PubMed/NCBI
4	Carter J, Tribe RM, Shennan AH and Sandall J: Threatened preterm labour: Women's experiences of risk and care management: A qualitative study. Midwifery. 64:85–92. 2018. View Article : Google Scholar : PubMed/NCBI
5	Wagner P, Sonek J, Heidemeyer M, Schmid M, Abele H, Hoopmann M and Kagan KO: Repeat measurement of cervical length in women with threatened preterm labor. Geburtshilfe Frauenheilkd. 76:779–784. 2016.(In German). View Article : Google Scholar : PubMed/NCBI
6	Malhotra N, Garg R, Malhotra N and Malhotra J: Oral allylestrenol: A pregnancy-supporting progestogen. J South Asian Fed Obstet Gynecol. 9:297–303. 2017.
7	Joshi P and Nayak A: Role of progesterone in threatened preterm labour. Indian Obstetr Gynaecol. 4:16–23. 2014.
8	Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ and Escobar-Morreale HF: Definition and significance of polycystic ovarian morphology: A task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 20:334–352. 2014. View Article : Google Scholar : PubMed/NCBI
9	Takekawa D, Jinushi K, Kitayama M and Hirota K: Rebound hyperkalemia after cessation of ritodrine in a parturient undergoing cesarean section. JA Clin Rep. 3:32017. View Article : Google Scholar : PubMed/NCBI
10	Yuan JL and Yang L: Efficacy observation of allylestrenol combined with ritodrine in treatment of habitual abortion. Zhongguo Yiyuan Yongyao Pingjia Yu Fenxi. 15:1580–1582. 2015.(In Chinese).
11	Zhu RY, Wong YC and Yong EL: Sonographic evaluation of polycystic ovaries. Best Pract Res Clin Obstet Gynaecol. 37:25–37. 2016. View Article : Google Scholar : PubMed/NCBI
12	Iliodromiti S, Mackay DF, Smith GC, Pell JP and Nelson SM: Apgar score and the risk of cause-specific infant mortality: A population-based cohort study. Lancet. 384:1749–1755. 2014. View Article : Google Scholar : PubMed/NCBI
13	Berghella V, Palacio M, Ness A, Alfirevic Z, Nicolaides KH and Saccone G: Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: Systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 49:322–329. 2017. View Article : Google Scholar : PubMed/NCBI
14	Paules C, Pueyo V, Martí E, de Vilchez S, Burd I, Calvo P and Oros D: Threatened preterm labor is a risk factor for impaired cognitive development in early childhood. Am J Obstet Gynecol. 216:157. e1–157. e7. 2017. View Article : Google Scholar
15	Xu YJ, Ren LD, Zhai SS, Ran LM, Hu LL, Luo XH, Hong T, Liu R, Yu YR and Ban YJ: OXTR and ZEB1 expression before and after progesterone dosing in pregnant women with threatened premature labor. Eur Rev Med Pharmacol Sci. 21:3164–3168. 2017.PubMed/NCBI
16	van Vliet EO, Boormans EM, de Lange TS, Mol BW and Oudijk MA: Preterm labor: Current pharmacotherapy options for tocolysis. Expert Opin Pharmacother. 15:787–797. 2014. View Article : Google Scholar : PubMed/NCBI
17	Kareli D, Pouliliou S, Liberis A, Nikas I, Psillaki A, Kontomanolis E, Nikolettos N, Galazios G and Lialiaris T: Genotoxic effect of tocolytic drug ritodrine in combination with smoking during pregnancy. J Matern Fetal Neonatal Med. 29:3496–3505. 2016.PubMed/NCBI
18	Kim MJ, Hwang I, Bae JY and Seong WJ: The influence of ritodrine alone or in combination with nifedipine on maternal cardiovascular side effects and pregnancy outcomes. Clin Exp Obstet Gynecol. 41:537–540. 2014.PubMed/NCBI
19	Kim MK, Lee SM, Oh JW, Kim SY, Jeong HG, Kim SM, Park CW, Jun JK, Hahn SK and Park JS: Efficacy and side effect of ritodrine and magnesium sulfate in threatened preterm labor. Obstet Gynecol Sci. 61:63–70. 2018. View Article : Google Scholar : PubMed/NCBI
20	Nigro G, Mazzocco M, Mattia E, Di Renzo GC, Carta G and Anceschi MM: Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med. 24:983–989. 2011. View Article : Google Scholar : PubMed/NCBI
21	Garcia-Ruíz G, Flores-Espinosa P, Preciado-Martínez E, Bermejo-Martínez L, Espejel-Nuñez A, Estrada-Gutierrez G, Maida-Claros R, Flores-Pliego A and Zaga-Clavellina V: In vitro progesterone modulation on bacterial endotoxin-induced production of IL-1β, TNFα, IL-6, IL-8, IL-10, MIP-1α, and MMP-9 in pre-labor human term placenta. Reprod Biol Endocrinol. 13:1152015. View Article : Google Scholar : PubMed/NCBI
22	Carp HJA: Progestogens and pregnancy loss. Climacteric. 21:380–384. 2018. View Article : Google Scholar : PubMed/NCBI
23	Koucký M, Malíčková K, Cindrová-Davies T, Smíšek J, Vráblíková H, Černý A, Šimják P, Slováčková M, Pařízek A and Zima T: Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy - Results of a pilot study. J Reprod Immunol. 116:35–41. 2016. View Article : Google Scholar : PubMed/NCBI
24	Alimohamadi S, Javadian P, Gharedaghi MH, Javadian N, Alinia H, Khazardoust S, Borna S and Hantoushzadeh S: Progesterone and threatened abortion: A randomized clinical trial on endocervical cytokine concentrations. J Reprod Immunol. 98:52–60. 2013. View Article : Google Scholar : PubMed/NCBI
25	Shah J and Baxi B: Identification of biomarkers for prediction of preterm delivery. J Med Soc. 30:3–14. 2016. View Article : Google Scholar